Fidelity® MSCI Health Care ETF (FHLC)
43.01
+0.39 +0.92%
NYSE Arca
Jan 17, 16:59
Delayed 2m
USD
FHLC Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
| 1 Year Fund Level Flows | Upgrade |
View All FHLC News
FHLC News
-
WireHeadlineTime (ET)
-
SA Breaking News01/04 13:48
-
SA Breaking News12/28 14:21
-
SA Breaking News12/14 12:36
-
SA Breaking News12/14 12:36
-
SA Breaking News12/03 16:56
-
SA Breaking News10/25 14:32
-
SA Breaking News08/24 04:46
-
SA Breaking News08/15 10:32
-
SA Breaking News08/01 08:24
-
SA Breaking News07/13 07:53
FHLC Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 0.14% | 0.16% | 2.10% | 69 |
| 3M | -5.21% | -5.22% | -3.24% | 42 |
| 6M | 0.66% | 0.63% | -6.00% | 11 |
| YTD | 3.15% | 3.12% | 6.77% | 84 |
| 1Y | 3.42% | 3.47% | 1.13% | 32 |
| 3Y | 12.24% | 12.26% | 10.33% | 28 |
| 5Y | 10.88% | 10.88% | 9.12% | 31 |
| 10Y | -- | -- | 15.99% | -- |
| 15Y | -- | -- | 10.38% | -- |
| 20Y | -- | -- | 10.13% | -- |
FHLC Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.08% | 0.08% | 0.00% |
| Stock | 99.92% | 99.92% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
FHLC Region Exposure
| Americas | 99.93% |
| North America | 99.92% |
| Latin America | 0.01% |
| Greater Europe | 0.06% |
| United Kingdom | 0.01% |
| Europe Developed | 0.05% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
FHLC Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.03% |
| Healthcare | 98.41% |
| Industrials | 0.07% |
| Real Estate | 0.00% |
| Technology | 1.49% |
| Utilities | 0.00% |
FHLC Stock Market Capitalization
| Giant | 49.15% |
| Large | 31.12% |
| Medium | 13.62% |
| Small | 5.43% |
| Micro | 0.67% |
FHLC Stock Style Exposure
| Large Cap Value | 10.34% |
| Large Cap Blend | 43.40% |
| Large Cap Growth | 26.87% |
| Mid Cap Value | 1.52% |
| Mid Cap Blend | 3.23% |
| Mid Cap Growth | 8.91% |
| Small Cap Value | 0.46% |
| Small Cap Blend | 1.48% |
| Small Cap Growth | 3.78% |
View More Holdings
As of Jan. 14, 2019
FHLC Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.97% | 129.11 | +0.84% |
| PFE | Pfizer Inc | 6.47% | 42.47 | +0.85% |
| UNH | UnitedHealth Group Inc | 6.22% | 261.00 | -0.18% |
| MRK | Merck & Co Inc | 5.08% | 75.65 | +1.39% |
| ABBV | AbbVie Inc | 3.34% | 87.10 | +1.81% |
| AMGN | Amgen Inc | 3.32% | 201.92 | +1.52% |
| ABT | Abbott Laboratories | 3.12% | 70.52 | +1.00% |
| MDT | Medtronic PLC | 2.98% | 87.60 | +0.70% |
| LLY | Eli Lilly and Co | 2.89% | 119.16 | +2.02% |
| TMO | Thermo Fisher Scientific Inc | 2.47% | 238.17 | +1.51% |
Advertisement
FHLC One Page Reports
- One Page Report Download
FHLC Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Fidelity Investments |
| Benchmark Index | |
|---|---|
MSCI USA IMI/Health Care GR USD |
100.0% |
FHLC Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 2.67 yrs |
| Amy Whitelaw | 0.25 yrs |
| Greg Savage | 5.11 yrs |
| Jennifer Hsui | 5.11 yrs |
| Rachel Aguirre | 0.25 yrs |
FHLC Net Fund Flows
| 1M | -26.35M |
| 3M | 177.84M |
| 6M | 339.79M |
| YTD | 559.82M |
| 1Y | 559.82M |
| 3Y | 635.12M |
| 5Y | 1.297B |
| 10Y | -- |
FHLC Risk Info
| Beta (5Y) | 1.006 |
| Max Drawdown (All) | 20.41% |
| Historical Sharpe (10Y) | -- |
| Historical Sortino (All) | 1.383 |
| 30-Day Rolling Volatility | 27.69% |
| Daily Value at Risk (VaR) 1% (All) | 2.61% |
| Monthly Value at Risk (VaR) 1% (All) | 9.32% |
FHLC Fundamentals
| Dividend Yield TTM (1-17-19) | 2.06% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 26.97 |
| Weighted Average Price to Sales Ratio | 1.785 |
| Weighted Average Price to Book Ratio | 3.824 |
| Weighted Median ROE | 14.19% |
| Weighted Median ROA | 4.35% |
| Forecasted Dividend Yield | 1.47% |
| Forecasted PE Ratio | 15.21 |
| Forecasted Price to Sales Ratio | 1.747 |
| Forecasted Price to Book Ratio | 3.545 |
| Number of Holdings | 357 |
FHLC Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.05% |
| Forecasted Book Value Growth | 6.47% |
| Forecasted Cash Flow Growth | 8.47% |
| Forecasted Earnings Growth | -2.36% |
| Forecasted Revenue Growth | 9.03% |
FHLC Attributes
| Key Dates | |
|---|---|
| Inception Date | 10/21/2013 |
| Termination Date | |
| Last Annual Report Date | 7/31/2018 |
| Last Prospectus Date | 11/29/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
FHLC Excel Add-In Codes
- Name: =YCI("FHLC","name")
- Broad Asset Class: =YCI("FHLC", "broad_asset_class")
- Broad Category: =YCI("FHLC", "broad_category_group")
- Prospectus Objective: =YCI("FHLC", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
